Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-CLOSE: Clopidogrel Monotherapy vs Extended DAPT
NCT03947229Phase 4Active, not recruiting
- Sponsor
- Yonsei University
- Start
- Aug 2019
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in coronary artery disease (CAD), sponsored by Yonsei University. Started Aug 2019; status: active, not recruiting.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03947229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03947229.